Treatment patterns in women with postmenopausal osteoporosis using abaloparatide: a real-world observational study.

Deborah T GoldTammy BeckettChad DealAndrew L JamesMahshid MohseniAbigail McMillanTom BaileyLeny Pearman John Caminis Yamei Wang Setareh A WilliamsJacqueline M Kernaghan

Published in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2024)

Most patients completed treatment with abaloparatide as prescribed, and over half continued with an antiresorptive agent. This favorable conduct may be the result of regular follow-up visits and accessibility to both medication and patient support services.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
primary care
mental health
postmenopausal women
emergency department
prognostic factors
combination therapy
adverse drug
replacement therapy